Thursday, February 19, 2026

Tinubu Signs Executive Order, Stops Tax on imported Pharmaceutical Inputs


President Bola Tinubu has signed an executive order to introduce zero tariffs, excise duties and value added tax (VAT) on imported pharmaceutical inputs.


This was disclosed by the coordinating minister of health and social welfare, Muhammad Ali Pate, in a statement on Friday, June 28, 2024.


“In a transformative move to revitalize the Nigerian health sector, His Excellency President Bola Ahmed Tinubu, GCFR @officialABAT, has signed an Executive Order aiming to increase local production of healthcare products (pharmaceuticals, diagnostics, devices such as needles and syringes, biologicals, medical textile, etc.).

Also Read:  2023: Tinubu Visits Alaafin, Seeks Endorsement for Presidential Ambition


The Minister of Justice and Attorney General of the Federation @FedMinOfJustice, Prince Lateef Olasunkanmi Fagbemi SAN, @LOFagbemi, is to now take the next steps towards codifying the new Order.


The Order introduces zero tariffs, excise duties and VAT on specified machinery, equipment and raw materials, aiming to reduce production costs and enhance our local manufacturers’ competitiveness.

Also Read:  Akala Had Faint Premonition That He Would Pass On — Grieving Aide


Specified items include Active Pharmaceutical Ingredients (AP|s), excipients, other essential raw materials required for manufacturing of crucial health products like drugs, syringes and needles, Long-lasting Insecticidal Nets (LLINs) and Rapid Diagnostic Kits, among others.


The Order also provides for establishing market shaping mechanisms such as framework contracts and volume guarantees, to encourage local manufacturers.

Also Read:  Police Uncover Syndicate Selling Human Body Parts for Rituals in Ibadan


The implication of this order is pivot towards market-based incentives to encourage medical industrialization, reducing costs of medical products through import substitution over time, creating and retaining economic value and enabling job creation in the healthcare value chain,” the minister said.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

Don't Miss

Categories

Tinubu Signs Executive Order, Stops Tax on imported Pharmaceutical Inputs


President Bola Tinubu has signed an executive order to introduce zero tariffs, excise duties and value added tax (VAT) on imported pharmaceutical inputs.


This was disclosed by the coordinating minister of health and social welfare, Muhammad Ali Pate, in a statement on Friday, June 28, 2024.


“In a transformative move to revitalize the Nigerian health sector, His Excellency President Bola Ahmed Tinubu, GCFR @officialABAT, has signed an Executive Order aiming to increase local production of healthcare products (pharmaceuticals, diagnostics, devices such as needles and syringes, biologicals, medical textile, etc.).

Also Read:  Ibadan chieftaincy review: APC chieftains laud Makinde, say effort in Ibadan’s best interest


The Minister of Justice and Attorney General of the Federation @FedMinOfJustice, Prince Lateef Olasunkanmi Fagbemi SAN, @LOFagbemi, is to now take the next steps towards codifying the new Order.


The Order introduces zero tariffs, excise duties and VAT on specified machinery, equipment and raw materials, aiming to reduce production costs and enhance our local manufacturers’ competitiveness.

Also Read:  Makinde Declares Tourism Sector Overhaul, Unveils 5-Point Reset Plan


Specified items include Active Pharmaceutical Ingredients (AP|s), excipients, other essential raw materials required for manufacturing of crucial health products like drugs, syringes and needles, Long-lasting Insecticidal Nets (LLINs) and Rapid Diagnostic Kits, among others.


The Order also provides for establishing market shaping mechanisms such as framework contracts and volume guarantees, to encourage local manufacturers.

Also Read:  Breaking: Oyo Govt Dissolves School Governing Boards in Public Secondary Schools


The implication of this order is pivot towards market-based incentives to encourage medical industrialization, reducing costs of medical products through import substitution over time, creating and retaining economic value and enabling job creation in the healthcare value chain,” the minister said.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

spot_imgspot_img
spot_img

Don't Miss

Categories

Related Articles